Gianluigi Ferretti

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study.

Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study.

Journal: NPJ breast cancer
Published: January 23, 2026

Multidisciplinary minimally invasive planning for synchronous breast cancer and thymoma: a scarless single-stage surgical strategy-a case report and literature review.

Multidisciplinary minimally invasive planning for synchronous breast cancer and thymoma: a scarless single-stage surgical strategy-a case report and literature review.

Journal: Gland surgery
Published: January 22, 2026

Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer.

Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 11, 2025

Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.

Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.

Journal: Biology direct
Published: May 02, 2025

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Journal: Cancers
Published: October 22, 2024

Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice.

Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice.

Journal: Frontiers in oncology
Published: September 25, 2024

Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.

Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.

Journal: Cancer treatment reviews
Published: June 21, 2024

Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.

Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.

Journal: NPJ precision oncology
Published: April 30, 2024

Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.

Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 22, 2024

Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients.

Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients.

Journal: Journal of experimental & clinical cancer research : CR
Published: February 12, 2024

Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study.

Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study.

Journal: Cancers
Published: August 30, 2023

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors.

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors.

Journal: Frontiers in oncology
Published: March 24, 2023
Showing 1-12 of 107

Last Updated: 09/26/2026